JWH 018 2-hydroxyindole metabolite(1427325-32-3)
- Name: JWH 018 2-hydroxyindole metabolite
- Synonyms:1427325-32-3;JWH 018 2-hydroxyindole metabolite;(2-hydroxy-1-pentylindol-3-yl)-naphthalen-1-ylmethanone;(2-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone;ZQYSLICSZDIUTJ-FCQUAONHSA-N;DTXSID301017815;CHC32532;JWH-018 2-hydroxyindole metabolite;J3.519.073B;1-Pentyl-3-(1-naphthylcarbonyl)-1H-indole-2-ol;3-(naphthalene-1-carbonyl)-1-pentyl-1H-indol-2-ol;(2-Hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone
- Molecular Formula:C24H23NO2
- Molecular Weight:357.4
- CAS Registry Number:1427325-32-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1427325-32-3 JWH 018 2-HYDROXYINDOLE METABOLITE
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1427325-32-3 JWH-018 2-Hydroxyindole Metabolite
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
Other Product
- 1333146-25-0/Benzamide, N-cyclohexyl-4-(1,6-dihydro-5-hydroxy-1-methyl-6-oxo-3-pyridinyl)-N-methyl-
- 1334302-64-5/rel-1-[(3R,4S)-1-[[3-Fluoro-2-(trifluoromethyl)-4-pyridinyl]carbonyl]-3-methoxy-4-piperidinyl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile
- 1308385-32-1/rel-(2R,2aS,5aS,8S,8aS,8bR)-Octahydro-8-iodo-1,2-bis(4-methylphenyl)pyrrolo[4,3,2-de]isoquinoline-3,5(1H,4H)-dione
- 96946-49-5/2,2'-(1,5-Pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium, (1alpha,2alpha(1'S*,2'S*))-
- 925447-04-7/Cerlapirdine hydrochloride
- 956136-98-4/Pradigastat sodium
- 1313514-79-2/[(5Z,8Z,11Z,14Z)-19-(cyclopropylamino)-19-oxononadeca-5,8,11,14-tetraenyl] 6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoate
- 1310686-26-0/Carbamic acid, N-[4-[(tricyclo[3.3.1.13,7]dec-1-ylcarbonyl)amino]butyl]-, 1,1-dimethylethyl ester
- 1344118-45-1/Furaquinocin I
- 339080-03-4/5,7-Dihydroxy-3-[[6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-beta-D-galactopyranosyl]oxy]-2-(3,4,5-trihydroxyphenyl)-1-benzopyrylium
- 1063408-69-4/tert-butyl 4-(6-amino-3,4-dihydroquinolin-1(2H)-yl)piperidine-1-carboxylate
- 1197193-29-5/2-(Methylsulfonyl)-4-morpholinobenzaldehyde
- 1809902-23-5/(2S)-2-[1-(alpha-D-Glucopyranosyloxy)-1-methylethyl]-2,3-dihydro-4-methoxy-7-methyl-5H-furo[3,2-g][1]benzopyran-5-one
- 250611-09-7/D-Tyrosine,N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-
- 139023-31-7/16,16-Difluoro-9,11,15-trihydroxyprost-5-en-1-oic acid
- 157283-72-2/15-Methyl-1-phosphanylidene-1-[(propan-2-yl)oxy]prosta-5,13-diene-9,11,15-triol
- 476310-24-4/(2-Hydroxy-2-oxo-1,2lambda~5~-oxaphospholan-5-yl)methyl octadec-9-enoate
- 1651833-51-0/JWH 200-d5 (exempt preparation)
- 1415744-44-3/Naphthalen-1-yl-[1-(2,2,3,3,4,4,5,5,5-nonadeuteriopentyl)indol-3-yl]methanone
- 1427325-32-3/JWH 018 2-hydroxyindole metabolite
- 1307803-46-8/JWH 073 4-hydroxyindole metabolite
- 335161-14-3/JWH 073 N-(4-hydroxybutyl) metabolite
- 1320363-50-5/JWH 073 N-butanoic acid metabolite-d5
- 2088449-88-9/Isopropyl 5-(diphenylphosphoryl)pentanoate
- 1651833-53-2/CID 53394755
- 1415744-43-2/JWH 073-d7 (exempt preparation)
- 1630022-99-9/JWH 073 5-hydroxyindole metabolite-d7
- 1020540-31-1/[1-(5-Chloro-1-benzothiophen-3-yl)-2-{[2-(3,5-dichlorophenyl)ethenyl]amino}-2-oxoethyl]phosphonic acid
- 1047654-47-6/4-(3-Fluorophenyl)pyrrolidine-3-carboxylic acid
- 1539217-84-9/Methyl 4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylate hydrochloride